Knowledge is a powerful tool for driving action. The right information, when delivered into the right hands, can create a convincing case for investing in global health.

A hurdle associated with the lack of investment in global health has been information – information about how the biopharmaceutical sector can invest in neglected diseases and how the global health community can design projects so that companies can invest.

To explore the many opportunities available in global health, and the importance of medical technology in combating diseases of the poor, BIO Ventures for Global Health has created a growing collection of case studies, business cases, and reports. These market-oriented publications are designed for policy makers and leaders in the biopharmaceutical industry and global health community, as well as anyone else who is interested in learning more about health issues facing the developing world.

The BIO Ventures for Global Health Library of Publications

Here are some of the BVGH publications that help make the business case for global health innovation:

Reports:

• The Diagnostics Innovation Map: Medical Diagnostics for the Unmet Needs of the Developing World
• Closing the Global Health Innovation Gap
• BVGH Global Health Primer (electronic) / PDF version
• Advance Market Commitments to Stimulate Industry Investment in Global Health Product Development

Case Studies

• Global Health Innovators: A Collection of Case Studies

Business Cases

• Tuberculosis Vaccines: The Case for Investment

Priority Review Vouchers (PRVs)

• PRV Resources